Navigation Links
New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging

Women Report Partner's Symptoms Negatively Affect Relationship

BOCA RATON, Fla., June 25, 2007 /PRNewswire/ -- Results of a new nationwide survey show that more than half of women whose male partners have symptoms of a medical condition known as low testosterone incorrectly attribute them to the normal course of aging. The survey also found that, while women believe their male partner's symptoms of low testosterone negatively impact their relationship, treatment of the condition improves the quality of the relationship.

Low testosterone, or testosterone deficiency associated with hypogonadism, is a medical condition caused by disease or damage to the testicles, hypothalamus, or pituitary gland that inhibits hormone secretion and testosterone production in men. As many as five million men over the age of 18 have lower than normal levels of testosterone.(1)

"Most people don't realize that low testosterone is a serious medical condition, and one that can have an impact on the entire family," said Tanya Abreu, President and National Program Director, Spirit of Women Health Network, which commissioned the survey. "If left untreated, low testosterone can affect a man's overall health, personal relationships, and quality of life. And, it can also affect his partner's perception of the relationship and quality of life. At Spirit of Women, we believe health is quality of life."

As reported by the women surveyed, symptoms of low testosterone in most symptomatic men included lack of energy (64%), decreased libido (61%), less strong erections (64%), a sad and/ or grumpy mood (58%), and irritability (60%). Symptoms most troublesome to women with a symptomatic partner are mood swings (91%), depression (91%), irritability (86%), a sad and/ or grumpy mood (81%), and decreased enjoyment of life (74%).

The online survey of 2,008 women aged 30 or older (mean age 45.8 years) in a romantic relationship f
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
Post Your Comments:
(Date:5/16/2008)...May 16 /- Data from three studies,eva...emoglobin (Hb) levels,and the rate of blood transf...ions on reimbursement for erythropoiesis-stimulati...n,s blood supply, will be presented at the,America...ng later this,month. The meeting will take place i...
(Date:5/16/2008)...16 /- Veridex, LLC announced today th...ion of America Holdings,(LabCorp), has commerciall...e cancer. The new assay uses the biological specif...ecting the methylation of the gene,GST-Pi. Methyla...y in,cancer. Veridex is developing the methylation...
(Date:5/15/2008)... May 15 /- Patients with breast or,co...ncers, can expect,further treatment advances with ...umab) following new data that is being presented a...ASCO) annual meeting in Chicago at,the end of May....ting which,is the premier event for cancer therapy...
(Date:5/15/2008)...a, May 15 /- Cytopia Limite... its upcoming oral,presentation on CYT997 at the 2...ical Oncology (ASCO) will be accessible to the pub...m 9pm on Thursday 15 May (US EDT)., The oral pres...a novel,cytotoxic and vascular disrupting agent, i...
Breaking Medicine Technology:New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 3New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 4New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 5New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 6New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6UCLA to lead local study center in landmark government study of child health 2933 1UCLA to lead local study center in landmark government study of child health 2933 2UCLA to lead local study center in landmark government study of child health 2933 3UCLA to lead local study center in landmark government study of child health 2933 4NAMI Statement on U S Senator Pete Domenici Retirement 2930 1Biomoda and Averion International Announce Agreement for Clinical Services 2926 1Biomoda and Averion International Announce Agreement for Clinical Services 2926 2Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting 1068 1Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting 1068 2Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting 1068 3Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting 1068 4Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting 1068 5Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting 1068 6
...N, Alberta, May 4, 2007 – Isotechnika Inc.,(...lead drug,ISA247, referred to as LX211 by our par...ject of two presentations at the,Association for R...meeting, being held May 6-10 in Fort Lauderdale, F...g given on May 5 during a,satellite session of the...
...EN, Conn.--(BUSINESS WIRE)--May 7, 2007 - NanoViri...of recent animal studies,against rabies and BSL3 i...uenza) virus at the 23rd Annual Symposium of the P..., FL, on Wednesday,May 2. (Pan American Society f...mposium), The BSL3 studies against Clade 2 H5N1, a...
Other Medicine Technology:Isotechnika's Lead Drug, ISA247, To Be Highlighted at the,Association for Research in Vision and Ophthalmology (ARVO) Annual,Meeting 2Isotechnika's Lead Drug, ISA247, To Be Highlighted at the,Association for Research in Vision and Ophthalmology (ARVO) Annual,Meeting 3Isotechnika's Lead Drug, ISA247, To Be Highlighted at the,Association for Research in Vision and Ophthalmology (ARVO) Annual,Meeting 4NanoViricides Drugs Found To Be Highly Effective Against Most,Recent Strain of the H5N1 Avian Flu Virus 2
(Date:5/16/2008).../PRNewswire/ -- ExamForce announced today the,hiri...rnment Sales Manager.,Mongeon formerly headed up t...s where he oversaw government sales and marketing ...op security certifications in the IT,industry., M...y left (ISC)2,Americas to spend more time with his...
(Date:5/16/2008)...s:, - 2007 Comprehensive Income increased 42% to ....9 million, - 2007 Gross Margin of 76%, - Produc...% to $12.2 million from $2.4 million as of Dece...Newswire-FirstCall/ -- Huiheng,Medical, Inc. ("Hui..., a,China-based leader in the development, sales a...
(Date:5/16/2008)... insulin-free for at least a year or two, , ...lanted islet cells help people with type 1 diabete...d appear to provide longer-term improved metabolic...ulin again, researchers report. , Using continu...he University of Miami Miller School of Medicine f...
(Date:5/16/2008)...6 /PRNewswire-USNewswire/ -- Karin Weisburgh,seni...fit publisher of,Consumer Reports magazine, was na...ar at CU,s Yonkers headquarters today., Ms. Weisb...ndles up in,the winter and rides in shirt sleeves ...along Quaker Ridge in New Rochelle, down Mill Road...
Breaking Medicine News(10 mins):Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 3Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 4Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 5Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 6Health News:Islet Cell Transplants Aid Type 1 Diabetics 2Health News:Islet Cell Transplants Aid Type 1 Diabetics 3Health News:Westchester Cycle Club Awards Consumers Union Staffer Karin Weisburgh Commuter of the Year 2Health News:Westchester Cycle Club Awards Consumers Union Staffer Karin Weisburgh Commuter of the Year 3
...dy is set up by the Indian information technology ...t of data, by 3 employees of a BPO firm. // The ma...ndustry. The move is to bolster overseas clients t...s have stirred the IT sector to set up a strict su...
...history of breast cancer could be allowed to use I... proposals that is due to be discussed by the gove... // WOMEN with inherited forms of breast cancer wi...rom genes that can cause the disease. This landma...
...hown that cutting back a few calories from our die...vent certain age related changes in cells. // Sc...e on Aging have found that eating a little less fo... lifespan can reduce or even reverse aging-related...
... in UK it was found that de- addiction drug help t... Health analyzed 1,383 people with Naltrexone//. T...study results were reported in the Journal of the ...ade accessible easily to all people thereby help i...
Other Medicine News:Health News:Women With Breast Cancer Can Now USE IVF To Spare Their Daughters 2Health News:Women With Breast Cancer Can Now USE IVF To Spare Their Daughters 3Health News:Cut Calories to Age Gracefully 2Health News:Cut Calories to Age Gracefully 3
The SoftTech Health Lab QMS (Quality Management System) is the first full-featured quality management system built specifically for healthcare labs. The Lab QMS was designed to help you meet quality
...er use both controlled temperature and agitation t...he safety of your plasma. The DH4 (4 bag) and DH8 ...controls that will accommodate a variety of bag co...o operate, allowing you to load, program, and walk...
Conventional Digitally-Controlled Water Baths
... group pf viruses. This virus is found commonly th... the sudden onset of fever, headache, pain in the ...h and retrobulbar pain.,This test is intended for ...i-Dengue IgM antibodies. The Bio-Quant,Dengue IgM ...
Medicine Products: